Press Releases & News Articles: National Institute of Neurological Disorders and Stroke (NINDS) Copyright 2015, National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/news_and_events/news_articles/index.htm en Press Release Saturday Sunday http://blogs.law.harvard.edu/tech/rss Untangling a cause of memory loss in neurodegenerative diseases http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_neurodegenerative_tauopathies_10112016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_neurodegenerative_tauopathies_10112016.htm Tauopathies are a group of neurodegenerative disorders, including Alzheimer’s disease that are characterized by the deposition of aggregates of the tau protein inside brain cells. A new study reveals that the cutting of tau by an enzyme called caspase-2 may play a critical role in the disordered brain circuit function that occurs in these diseases. Of interest, the culprit tau fragment identified in this study is actually resistant to forming aggregates, and it causes a disturbance in memory function in animal models before brain cell loss occurs. Tue, 11 Oct 2016 00:00:00 EDT Targeting cardiovascular disease risk factors may be important across a lifetime http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_REGARDS_CVD_10052016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_REGARDS_CVD_10052016.htm New findings suggest that all adults, including those over 65, should be mindful of risk factors for cardiovascular disease. The results, published in the Journal of the American Geriatric Society, are part of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, which looks at stroke incidence in approximately 30,000 individuals. The REGARDS study is funded by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS). Wed, 05 Oct 2016 00:00:00 EDT Researchers find a gap in the brain’s firewall against Parkinson’s disease http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_LAG3_pd_09302016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_LAG3_pd_09302016.htm In a study in mice, researchers found that they could reduce the progression of the toxic aggregates of α-synuclein that are found in the brains of Parkinson’s disease patients. The results suggest that a protein called lymphocyte-activation gene 3 (LAG3) plays a role in transmitting α-synuclein aggregates from one brain cell to another and could provide a possible target to slow the progression of Parkinson’s disease. The study, published in Science, was partially funded by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS). Fri, 30 Sep 2016 00:00:00 EDT “Sixth sense” may be more than just a feeling http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_sixth_sense_09232016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_sixth_sense_09232016.htm With the help of two young patients with a unique neurological disorder, an initial study by scientists at the National Institutes of Health suggests that a gene called PIEZO2 controls specific aspects of human touch and proprioception, a “sixth sense” describing awareness of one’s body in space. Mutations in the gene caused the two to have movement and balance problems and the loss of some forms of touch. Despite their difficulties, they both appeared to cope with these challenges by relying heavily on vision and other senses. Fri, 23 Sep 2016 00:00:00 EDT New members appointed to National Advisory Neurological Disorders and Stroke Council http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_nands_council_09152016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_nands_council_09152016.htm Four distinguished individuals from the neuroscience community have been chosen to serve on the National Advisory Neurological Disorders and Stroke Council, the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. Thu, 15 Sep 2016 00:00:00 EDT NINDS Names Dr. Clinton B. Wright as Director of the Office of Clinical Research http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_ocr_director_dr-clinton-wright_09152016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_ocr_director_dr-clinton-wright_09152016.htm The National Institute of Neurological Disorders and Stroke (NINDS) has named vascular neurologist Clinton B. Wright, M.D., M.S., as director of its Office of Clinical Research (OCR) and associate director of the institute. Dr. Wright is expected to join the NINDS in November. NINDS is part of the National Institutes of Health (NIH). Thu, 15 Sep 2016 00:00:00 EDT Stem cell therapy heals injured mouse brain http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_stem_cell_therapy_08222016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_stem_cell_therapy_08222016.htm Scientists and clinicians have long dreamed of helping the injured brain repair itself by creating new neurons, and an innovative NIH-funded study published today in Nature Medicine may bring this goal much closer to reality. A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage. Mon, 22 Aug 2016 00:00:00 EDT Researchers examine how Parkinson’s disease alters brain activity over time http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_pd_brain_changes_08152016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_pd_brain_changes_08152016.htm Neuroscientists peered into the brains of patients with Parkinson’s disease and two similar conditions to see how their neural responses changed over time. The study, funded by the NIH’s Parkinson’s Disease Biomarkers Program and published today in Neurology, may provide a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain. Mon, 15 Aug 2016 00:00:00 EDT NIH-funded study supports surgery as treatment for myasthenia gravis http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_myasthenia_gravis_08102016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_myasthenia_gravis_08102016.htm In a global study of myasthenia gravis, an autoimmune disease that causes muscle weakness and fatigue, researchers found that surgical removal of an organ called the thymus reduced patients’ weakness, and their need for immunosuppressive drugs. The study, published in the New England Journal of Medicine, was partially funded by the National Institutes of Health. Wed, 10 Aug 2016 00:00:00 EDT Novel genetic mutation may lead to the progressive loss of motor function http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_neuropathy_08032016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_neuropathy_08032016.htm Researchers from the National Institutes of Health and their colleagues identified the genetic cause and a possible therapeutic target for a rare form of pediatric progressive neuropathy. Neuropathy, damage or disease affecting the peripheral nervous system, can range from rare conditions linked to a patient’s exome to more common causes like diabetes and viral infections. Wed, 03 Aug 2016 00:00:00 EDT New imaging method may predict risk of post-treatment brain bleeding after stroke http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_bleeding_stroke_brain_06172016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_bleeding_stroke_brain_06172016.htm In a study of stroke patients, investigators confirmed through MRI brain scans that there was an association between the extent of disruption to the brain’s protective blood-brain barrier and the severity of bleeding following invasive stroke therapy. The results of the National Institutes of Health-funded study were published in Neurology. Fri, 17 Jun 2016 00:00:00 EDT Standard blood pressure target is sufficient for treating some strokes http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_bp_strokes_06082016.htm http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_bp_strokes_06082016.htm An international stroke study found that standard and intensive blood pressure treatments were equally effective in the emergency treatment of acute intracerebral hemorrhage, a type of stroke caused by bleeding into the brain. Patients whose systolic blood pressure was reduced rapidly in emergency rooms to standard levels used to treat acute stroke (140-179 mm Hg) did as well as patients whose pressure was reduced to intensive levels (110-139 mm Hg). The study, published in the New England Journal of Medicine, was funded by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS). Wed, 08 Jun 2016 00:00:00 EDT